A history of poly A sequences: from formation to factors to function - PubMed (original) (raw)
Review
A history of poly A sequences: from formation to factors to function
Mary Edmonds. Prog Nucleic Acid Res Mol Biol. 2002.
Abstract
Biological polyadenylation, first recognized as an enzymatic activity, remained an orphan enzyme until poly A sequences were found on the 3' ends of eukarvotic mRNAs. Their presence in bacteria viruses and later in archeae (ref. 338) established their universality. The lack of compelling evidence for a specific function limited attention to their cellular formation. Eventually the newer techniques of molecular biology and development of accurate nuclear processing extracts showed 3' end formation to be a two-step process. Pre-mRNA was first cleaved endonucleolytically at a specific site that was followed by sequential addition of AMPs from ATP to the 3' hydroxyl group at the end of mRNA. The site of cleavage was specified by a conserved hexanucleotide, AAUAAA, from 10 to 30 nt upstream of this 3' end. Extensive purification of these two activities showed that more than 10 polypeptides were needed for mRNA 3' end formation. Most of these were in complexes involved in the cleavage step. Two of the best characterized are CstF and CPSF, while two other remain partially purified but essential. Oddly, the specific proteins involved in phosphodiester bond hydrolysis have yet to be identified. The polyadenylation step occurs within the complex of poly A polymerase and poly A-binding protein, PABII, that controls poly A length. That the cleavage complex, CPSF, is also required for this step attests to a tight coupling of the two steps of 3' and formation. The reaction reconstituted from these RNA-free purified factors correctly processes pre-mRNAs. Meaningful analysis of the role of poly A in mRNA metabolism or function was possible once quantities of these proteins most often over-expressed from cDNA clones became available. The large number needed for two simple reactions of an endonuclease, a polymerase and a sequence recognition factor, pointed to 3' end formation as a regulated process. Polyadenylation itself had appeared to require regulation in cases where two poly A sites were alternatively processed to produce mRNA coding for two different proteins. The 64-KDa subunit of CstF is now known to be a regulator of poly A site choice between two sites in the immunoglobulin heavy chain of B cells. In resting cells the site used favors the mRNA for a membrane-bound protein. Upon differentiation to plasma cells, an upstream site is used the produce a secreted form of the heavy chain. Poly A site choice in the calcitonin pre-mRNA involves splicing factors at a pseudo splice site in an intron downstream of the active poly site that interacts with cleavage factors for most tissues. The molecular basis for choice of the alternate site in neuronal tissue is unknown. Proteins needed for mRNA 3' end formation also participate in other RNA-processing reactions: cleavage factors bind to the C-terminal domain of RNA polymerase during transcription; splicing of 3' terminal exons is stimulated port of by cleavage factors that bind to splicing factors at 3' splice sites. nuclear ex mRNAs is linked to cleavage factors and requires the poly A II-binding protein. Most striking is the long-sought evidence for a role for poly A in translation in yeast where it provides the surface on which the poly A-binding protein assembles the factors needed for the initiation of translation. This adaptability of eukaryotic cells to use a sequence of low information content extends to bacteria where poly A serves as a site for assembly of an mRNA degradation complex in E. coli. Vaccinia virus creates mRNA poly A tails by a streamlined mechanism independent of cleavage that requires only two proteins that recognize unique poly A signals. Thus, in spite of 40 years of study of poly A sequences, this growing multiplicity of uses and even mechanisms of formation seem destined to continue.
Similar articles
- CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition.
Gilmartin GM, Fleming ES, Oetjen J, Graveley BR. Gilmartin GM, et al. Genes Dev. 1995 Jan 1;9(1):72-83. doi: 10.1101/gad.9.1.72. Genes Dev. 1995. PMID: 7828853 - The 64-kilodalton subunit of the CstF polyadenylation factor binds to pre-mRNAs downstream of the cleavage site and influences cleavage site location.
MacDonald CC, Wilusz J, Shenk T. MacDonald CC, et al. Mol Cell Biol. 1994 Oct;14(10):6647-54. doi: 10.1128/mcb.14.10.6647-6654.1994. Mol Cell Biol. 1994. PMID: 7935383 Free PMC article. - Dependence of yeast pre-mRNA 3'-end processing on CFT1: a sequence homolog of the mammalian AAUAAA binding factor.
Stumpf G, Domdey H. Stumpf G, et al. Science. 1996 Nov 29;274(5292):1517-20. doi: 10.1126/science.274.5292.1517. Science. 1996. PMID: 8929410 - 3'-End processing of pre-mRNA in eukaryotes.
Wahle E, Rüegsegger U. Wahle E, et al. FEMS Microbiol Rev. 1999 Jun;23(3):277-95. doi: 10.1111/j.1574-6976.1999.tb00400.x. FEMS Microbiol Rev. 1999. PMID: 10371034 Review. - Implications of polyadenylation in health and disease.
Curinha A, Oliveira Braz S, Pereira-Castro I, Cruz A, Moreira A. Curinha A, et al. Nucleus. 2014;5(6):508-19. doi: 10.4161/nucl.36360. Epub 2014 Oct 31. Nucleus. 2014. PMID: 25484187 Free PMC article. Review.
Cited by
- The GLD-2 poly(A) polymerase activates gld-1 mRNA in the Caenorhabditis elegans germ line.
Suh N, Jedamzik B, Eckmann CR, Wickens M, Kimble J. Suh N, et al. Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15108-12. doi: 10.1073/pnas.0607050103. Epub 2006 Sep 29. Proc Natl Acad Sci U S A. 2006. PMID: 17012378 Free PMC article. - GLD-2/RNP-8 cytoplasmic poly(A) polymerase is a broad-spectrum regulator of the oogenesis program.
Kim KW, Wilson TL, Kimble J. Kim KW, et al. Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17445-50. doi: 10.1073/pnas.1012611107. Epub 2010 Sep 20. Proc Natl Acad Sci U S A. 2010. PMID: 20855596 Free PMC article. - A bipartite U1 site represses U1A expression by synergizing with PIE to inhibit nuclear polyadenylation.
Guan F, Caratozzolo RM, Goraczniak R, Ho ES, Gunderson SI. Guan F, et al. RNA. 2007 Dec;13(12):2129-40. doi: 10.1261/rna.756707. Epub 2007 Oct 17. RNA. 2007. PMID: 17942741 Free PMC article. - Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1.
Winter J, Kunath M, Roepcke S, Krause S, Schneider R, Schweiger S. Winter J, et al. BMC Mol Biol. 2007 Nov 15;8:105. doi: 10.1186/1471-2199-8-105. BMC Mol Biol. 2007. PMID: 18005432 Free PMC article. - Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus.
Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC, Plenge RM, Koeuth T, Ortmann WA, Hom G, Bauer JW, Gillett C, Burtt N, Cunninghame Graham DS, Onofrio R, Petri M, Gunnarsson I, Svenungsson E, Rönnblom L, Nordmark G, Gregersen PK, Moser K, Gaffney PM, Criswell LA, Vyse TJ, Syvänen AC, Bohjanen PR, Daly MJ, Behrens TW, Altshuler D. Graham RR, et al. Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6758-63. doi: 10.1073/pnas.0701266104. Epub 2007 Apr 5. Proc Natl Acad Sci U S A. 2007. PMID: 17412832 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials